Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Jiangsu Guoxin: Guoxin Bindian's 1000MW unit was officially put into production. Jiangsu Guoxin announced that a 1000MW secondary reheat ultra-supercritical coal-fired generator set newly built by its holding subsidiary Guoxin Bindian completed its 168-hour full-load trial operation and was officially put into operation on December 11, 2024.
The National Network Information Office concentrated on rectifying the chaos of online financial information. Since this year, the National Network Information Office has thoroughly implemented the work plan of the CPC Central Committee in the State Council, maintained a high-pressure and severe crackdown on the chaos of online financial information, and handled a number of accounts engaged in illegal stock recommendation, illegal financial intermediary and other activities on platforms such as Tik Tok, Aauto Quicker, Weibo and WeChat with relevant departments, cleaned up the drainage and induced illegal information in the financial field, and increased the punishment for websites and accounts that are not qualified to engage in financial-related business. For the website platform engaged in loan assistance business, it is required to standardize marketing information display and marketing function setting, and strengthen information risk disclosure. In the next step, the national network information department will continue to strengthen the crackdown and rectification of online financial information chaos, standardize the order of online financial information dissemination, and strive to safeguard people's property safety. (Net letter China)As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.Zhengshang Institute: Xinfengming Jiangsu Xintuo New Materials Co., Ltd. was added as the designated short fiber delivery warehouse. Zhengzhou Commodity Exchange announced on the 11th that after research, Xinfengming Jiangsu Xintuo New Materials Co., Ltd. was added as the designated short fiber delivery warehouse, and the short fiber futures delivery business was started from the date of announcement, with the daily minimum delivery speed of 1,000 tons/day and the premium of 0 yuan/ton.
Jizhi Co., Ltd.: Signed a supplementary agreement on development cooperation of 1.1 million yuan, and Jizhi Co., Ltd. announced that the company signed a supplementary agreement on entrusted development cooperation projects with Jiang Laboratory and Hangzhou Dilting Intelligent Technology Co., Ltd. According to the agreement, all parties have completed the development of intelligent underwater acoustic signal products, and will accelerate the application, promotion and industrialization of related products. The supplementary agreement stipulates that Jizhi shares will donate 1.1 million yuan to Zhejiang Zhijiang Development Foundation for public welfare. The signing of this agreement does not involve related party transactions, nor does it constitute a major asset restructuring. It still needs to be submitted to the company's second extraordinary shareholders meeting in 2024 for consideration. The signing of the agreement has limited impact on the company's short-term financial situation, but it is expected to have important strategic significance for the company's business development in the process of industrialization of related products.Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.Shell Tianjin Investment Co., Ltd. increased its capital to 600 million US dollars. Tianyancha App shows that recently, Shell Tianjin Investment Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 550 million US dollars to 600 million US dollars. The company was established in September 2018, and its legal representative is Peng Yongdong, which is wholly owned by Hongkong Enjoying International Limited.
Strategy guide 12-13
Strategy guide
Strategy guide
Strategy guide 12-13
Strategy guide
12-13